Results 11 to 20 of about 3,547,100 (335)

Tumor Vasculature

open access: yesMolecular Imaging, 2021
S. Notohamiprodjo   +6 more
semanticscholar   +2 more sources

Gold nanoparticle-enhanced radiotherapy: Dependence of the macroscopic dose enhancement on the microscopic localization of the nanoparticles within the tumor vasculature. [PDF]

open access: yesPLoS ONE
In gold nanoparticle-enhanced radiotherapy, intravenously administered nanoparticles tend to accumulate in the tumor tissue by means of the so-called permeability and retention effect and upon irradiation with x-rays, the nanoparticles release a ...
C A Díaz-Galindo, H M Garnica-Garza
doaj   +2 more sources

Non-immune functions of B7-H3: bridging tumor cells and the tumor vasculature [PDF]

open access: yesFrontiers in Oncology
B7-H3 (CD276), an immune checkpoint molecule, is overexpressed in various types of cancer and their tumor vasculature, demonstrating significant associations with adverse clinical outcomes.
Shuo Wu   +4 more
doaj   +2 more sources

Blockade of the CD93 pathway normalizes tumor vasculature to facilitate drug delivery and immunotherapy

open access: yesScience Translational Medicine, 2021
Disruption of the molecular interaction between CD93 and IGFBP7 improves tumor vascular functions and thereby facilitates therapeutic interventions. Fixing faulty tumor vessels Solid tumors have structurally abnormal blood vessels that lead to decreased ...
Yi Sun   +22 more
semanticscholar   +1 more source

Angiogenesis modulated by CD93 and its natural ligands IGFBP7 and MMRN2: a new target to facilitate solid tumor therapy by vasculature normalization

open access: yesCancer Cell International, 2023
The tumor vasculature was different from the normal vasculature in both function and morphology, which caused hypoxia in the tumor microenvironment (TME). Previous anti-angiogenesis therapy had led to a modest improvement in cancer immunotherapy. However,
Yang Li   +12 more
doaj   +1 more source

Directing CAR T cells towards the tumor vasculature for the treatment of solid tumors.

open access: yesBiochimica et biophysica acta. Reviews on cancer, 2022
For successful application of chimeric antigen receptor (CAR) T cell therapy in solid tumors, major hurdles have to be overcome. CAR T cells have to cross the vascular barrier, which is hampered by the anergic state of the tumor vasculature ...
P. Akbari   +6 more
semanticscholar   +1 more source

Normalizing Tumor Vasculature to Reduce Hypoxia, Enhance Perfusion, and Optimize Therapy Uptake

open access: yesCancers, 2021
Simple Summary In order for solid tumors to grow, they need to develop new blood vessels in order to support their increasing metabolic requirements. To facilitate the novel vessel formation, the tumor initiates an aggressive pro-angiogenic program. As a
K. Matuszewska   +4 more
semanticscholar   +1 more source

Heterogeneity of tumor vasculature and antiangiogenic intervention: insights from MR angiography and DCE-MRI. [PDF]

open access: yesPLoS ONE, 2014
Solid tumor vasculature is highly heterogeneous, which presents challenges to antiangiogenic intervention as well as the evaluation of its therapeutic efficacy.
Wenlian Zhu   +2 more
doaj   +1 more source

Endothelial YAP/TAZ Signaling in Angiogenesis and Tumor Vasculature

open access: yesFrontiers in Oncology, 2021
Solid tumors are dependent on vascularization for their growth. The hypoxic, stiff, and pro-angiogenic tumor microenvironment induces angiogenesis, giving rise to an immature, proliferative, and permeable vasculature.
Aukie Hooglugt   +3 more
semanticscholar   +1 more source

Priming a vascular-selective cytokine response permits CD8+ T-cell entry into tumors

open access: yesNature Communications, 2023
Targeting DNA methyltransferase 1 (DNMT1) has immunomodulatory and anti-neoplastic activity, especially when paired with cancer immunotherapies. Here we explore the immunoregulatory functions of DNMT1 in the tumor vasculature of female mice.
Dae Joong Kim   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy